ClinicalTrials.govpublic full text
ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
pancreatic cancer, pdac, pancreatic ductal adenocarcinoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 835522
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.